EE200100375A - Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicament - Google Patents

Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicament

Info

Publication number
EE200100375A
EE200100375A EEP200100375A EEP200100375A EE200100375A EE 200100375 A EE200100375 A EE 200100375A EE P200100375 A EEP200100375 A EE P200100375A EE P200100375 A EEP200100375 A EE P200100375A EE 200100375 A EE200100375 A EE 200100375A
Authority
EE
Estonia
Prior art keywords
medicament
manufacture
preparation
methods
telmisartan
Prior art date
Application number
EEP200100375A
Other languages
Estonian (et)
Inventor
Schneider Heinrich
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100375A publication Critical patent/EE200100375A/en
Publication of EE04344B1 publication Critical patent/EE04344B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
EEP200100375A 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament EE04344B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19901921A DE19901921C2 (en) 1999-01-19 1999-01-19 Polymorphs of telmisartan, process for their preparation and their use in the manufacture of a medicament
PCT/EP2000/000065 WO2000043370A1 (en) 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament

Publications (2)

Publication Number Publication Date
EE200100375A true EE200100375A (en) 2002-10-15
EE04344B1 EE04344B1 (en) 2004-08-16

Family

ID=7894715

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100375A EE04344B1 (en) 1999-01-19 2000-01-07 Telmisartan polymorphs, methods for their preparation and their use in the preparation of a medicament

Country Status (36)

Country Link
EP (1) EP1144386B1 (en)
JP (1) JP4700813B2 (en)
KR (1) KR100658959B1 (en)
CN (1) CN1144790C (en)
AR (1) AR035475A1 (en)
AT (1) ATE252564T1 (en)
AU (1) AU765081B2 (en)
BG (1) BG65027B1 (en)
BR (1) BR0007584A (en)
CA (1) CA2352436C (en)
CO (1) CO5150238A1 (en)
CZ (1) CZ297412B6 (en)
DE (2) DE19901921C2 (en)
DK (1) DK1144386T3 (en)
EA (1) EA003065B1 (en)
EE (1) EE04344B1 (en)
ES (1) ES2208265T3 (en)
HK (1) HK1041485B (en)
HR (1) HRP20010514B1 (en)
HU (1) HU227401B1 (en)
IL (2) IL143634A0 (en)
MY (1) MY122755A (en)
NO (1) NO319823B1 (en)
NZ (1) NZ513528A (en)
PE (1) PE20001362A1 (en)
PL (1) PL211829B1 (en)
PT (1) PT1144386E (en)
RS (1) RS50044B (en)
SA (1) SA99200838B1 (en)
SK (1) SK285429B6 (en)
TR (1) TR200102074T2 (en)
TW (1) TWI280241B (en)
UA (1) UA56358C2 (en)
UY (1) UY25980A1 (en)
WO (1) WO2000043370A1 (en)
ZA (1) ZA200104771B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153737A1 (en) * 2001-10-31 2003-05-28 Boehringer Ingelheim Pharma Crystalline sodium salt of telmisartan, process for its preparation and its use for the manufacture of a medicament
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
RS52012B (en) 2002-01-16 2012-04-30 Boehringer Ingelheim Pharma Gmbh&Co.Kg. Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
DE10314702A1 (en) 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
KR20070061583A (en) 2004-10-15 2007-06-13 테바 파마슈티컬 인더스트리즈 리미티드 Process for preparing telmisartan
WO2006044754A2 (en) 2004-10-18 2006-04-27 Dr. Reddy's Laboratories Ltd. Process for preparing telmisartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
MX346039B (en) 2009-05-20 2017-03-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical oral telmisartan solution.
PL2443094T3 (en) 2009-06-19 2013-08-30 Krka Tovarna Zdravil D D Novo Mesto Process for the preparation of telmisartan
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
WO2011002423A2 (en) 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
EP2448575A2 (en) 2009-07-02 2012-05-09 Bilgic Mahmut Pharmaceutical composition increasing solubility and stability
EA025946B1 (en) 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Multilayer pharmaceutical composition comprising telmisartan and amlodipine
ITMI20102416A1 (en) * 2010-12-27 2012-06-28 Chemelectiva S R L INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE AND PROCESS FOR ITS PREPARATION
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
JP6147546B2 (en) * 2013-04-10 2017-06-14 株式会社トクヤマ Method for producing telmisartan A-type crystals with reduced acetic acid
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP6275596B2 (en) * 2014-09-03 2018-02-07 株式会社トクヤマ Method for producing ammonium salt of telmisartan
JP5871294B1 (en) 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Immediate release oral tablets
KR20170001921A (en) 2015-06-26 2017-01-05 대원제약주식회사 A pharmaceutical composition comprising telmisartan with increased stability and a preparation method thereof
KR20170012703A (en) 2015-07-22 2017-02-03 대원제약주식회사 A pharmaceutical composition comprising telmisartan and a preparation method thereof
US20200316029A1 (en) 2016-05-30 2020-10-08 Boehringer Ingelheim International Gmbh Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
KR102044223B1 (en) * 2016-09-12 2019-11-13 성균관대학교산학협력단 Solid dispersions comprising Telmisartan and the preparation method thereof
CN106749037B (en) * 2016-12-21 2019-06-21 山东大学 A kind of unformed Telmisartan-glutaric acid eutectic and its preparation method and application
CN106749036B (en) * 2016-12-21 2019-06-21 山东大学 A kind of unformed Telmisartan-pimelic acid eutectic and its preparation method and application
CA3067918A1 (en) 2017-07-07 2019-01-10 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats
CN109851562A (en) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 A kind of Telmisartan crystal and preparation method thereof
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (en) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoles, drugs with this compounds, and process for their preparation
US5139114A (en) * 1991-03-18 1992-08-18 Abex Corporation Visible brake block wear indicator

Also Published As

Publication number Publication date
WO2000043370A1 (en) 2000-07-27
CN1336920A (en) 2002-02-20
JP4700813B2 (en) 2011-06-15
MY122755A (en) 2006-05-31
IL143634A (en) 2006-10-05
NO20013560D0 (en) 2001-07-18
BG105654A (en) 2002-01-31
ATE252564T1 (en) 2003-11-15
KR100658959B1 (en) 2006-12-19
CZ20012634A3 (en) 2001-10-17
TWI280241B (en) 2007-05-01
NO20013560L (en) 2001-09-18
YU51101A (en) 2004-05-12
PE20001362A1 (en) 2000-12-15
CO5150238A1 (en) 2002-04-29
NO319823B1 (en) 2005-09-19
EA200100730A1 (en) 2002-02-28
JP2002535315A (en) 2002-10-22
EP1144386B1 (en) 2003-10-22
EA003065B1 (en) 2002-12-26
KR20010101552A (en) 2001-11-14
UY25980A1 (en) 2001-08-27
HUP0105148A3 (en) 2003-01-28
BR0007584A (en) 2001-11-06
ES2208265T3 (en) 2004-06-16
CZ297412B6 (en) 2006-12-13
CN1144790C (en) 2004-04-07
AU765081B2 (en) 2003-09-11
EP1144386A1 (en) 2001-10-17
HRP20010514A2 (en) 2002-08-31
SK285429B6 (en) 2007-01-04
UA56358C2 (en) 2003-05-15
TR200102074T2 (en) 2001-12-21
BG65027B1 (en) 2006-12-29
NZ513528A (en) 2003-08-29
IL143634A0 (en) 2002-04-21
DE19901921A1 (en) 2000-08-03
DE19901921C2 (en) 2001-01-04
PL349425A1 (en) 2002-07-29
HU227401B1 (en) 2011-05-30
HUP0105148A2 (en) 2002-07-29
SK10202001A3 (en) 2001-12-03
ZA200104771B (en) 2002-12-02
HK1041485B (en) 2004-10-08
PL211829B1 (en) 2012-06-29
HRP20010514B1 (en) 2010-01-31
RS50044B (en) 2008-11-28
PT1144386E (en) 2004-03-31
AU2288100A (en) 2000-08-07
SA99200838B1 (en) 2006-03-06
AR035475A1 (en) 2004-06-02
DE50004150D1 (en) 2003-11-27
HK1041485A1 (en) 2002-07-12
DK1144386T3 (en) 2004-01-12
EE04344B1 (en) 2004-08-16
CA2352436C (en) 2010-03-23
CA2352436A1 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
EE200100375A (en) Telmisartan polymorphs, methods for their preparation and their use in the manufacture of a medicament
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
EE200300048A (en) Benzimidazole derivatives, their preparation and therapeutic use
EE04236B1 (en) Benzimidazoles, their preparation and use as medicaments
EE200200602A (en) Long-acting beta-mimetics, a process for their preparation and their use as medicaments
EE04565B1 (en) Adamantane derivatives, their preparation and use
EE04464B1 (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
NO2013004I1 (en) axitinib, optionally in the form of a pharmaceutical accentible salt
EE200100470A (en) Pyridopyranoazepine derivatives, their preparation and therapeutic use
EE200200064A (en) Arylmethylcarbonylaminothiazole derivatives, their preparation and their use as anticancer agents
EE200000037A (en) Acylpiperazinylpyrimidines Derivatives, Their Preparation and Use as Medicaments
IL149400A0 (en) Indeno-, naphtho-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
EE200100422A (en) Epothilone derivatives, process for their preparation and pharmaceutical use
NO20015148L (en) New pharmaceutical preparation
PT1200444E (en) NEW XANTONE COMPOUNDS, ITS PREPARATION AND ITS USE AS A DRUG
NO20015104D0 (en) New pharmaceutical preparation
EE04837B1 (en) Echinocandin derivatives, process for their preparation and use as antimycotics
NO20015105D0 (en) New pharmaceutical preparation
SI1144386T1 (en) Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
FI991396A0 (en) 5-substituted 3-hydroxybenzoates, process for their preparation and their use
IT1312082B1 (en) MORPHINOID DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC USE.
IT246525Y1 (en) COMPOSITE MANUFACTURE PERFECTED FOR USE IN BUILDING
FI20002361A (en) A process for preparing a pharmaceutical composition and the use of the composition
FI20002362A (en) A process for preparing a pharmaceutical composition and the use of the composition
SI1309594T1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150107